【摘要】 目的:在前人研究基础上进一步调查和研究类风湿关节炎(RA)患者药物治疗的规范化状况。方法:对湘潭市中心医院2012年3月至12月门诊就诊的120例风湿关节炎患者进行问卷调查。内容包括患者个人资料、就诊及确诊时间、科室,随诊时间间隔以及改善病情抗风湿药(DMARDs)的应用情况。结果:类风湿关节炎药物治疗不规范,甲氨蝶呤是患者应用最多的DMARDs,占60%,其次为来氟米特(30%)、柳氮磺吡啶(5%)及羟氯喹(5%)。结论:51%以上的RA病人DMARDs治疗不规范,尤其是在县级基层医院。类风湿性疾病的规范治疗需要从早期诊断治疗,优化联合用药,个性化治疗,定期跟踪疗效等方面来规范。更多还原

【Abstract】 Objective:To investigate the current situation of rheumatoid arthritis(RA) diagnosing and curing based on previous study.Methods:120 Rheumatoid arthritis(RA) patients were chosen for the investigation from March to December,including their personal information,the time for diagnosing,department and the usage of the DMARDs.Results:Methotrexate was considered to be the most popular ones in DMARDs,accounting for 60%;Besides,leflunomide takes up 30%,sulfasalazine 5% and hydroxychlo-roquine 5%.Conclusion:50% rheumatoid arthritis patients were not give an appropriate treatment in our country,especially in basic-level hospitals at or above the county level.Rheumatoid disease standard therapy needs improved from the aspect of early diagnosis and treatment,optimize of the combination therapy,personalized treatment,and regular tracking effect.更多还原